Cargando…
Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
Eltrombopag can be used safely as upfront medication in the management of ulcerative colitis as well as ITP, and it showed a beneficial effect in both disorders.
Autores principales: | Abdelmahmuod, Elabbass A., Ali, Elrazi, Ahmed, Mohanad A., Yassin, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981772/ https://www.ncbi.nlm.nih.gov/pubmed/33768857 http://dx.doi.org/10.1002/ccr3.3783 |
Ejemplares similares
-
Eltrombopag Dose Adjustment During Infection-Induced Thrombocytosis in a Patient With Chronic Idiopathic Thrombocytopenic Purpura
por: Ahmed, Mohanad, et al.
Publicado: (2021) -
Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab
por: Ahmed, Mohanad, et al.
Publicado: (2020) -
The Relationship Between Sickle Cell Disease and Sudden Onset Sensorineural Deafness
por: Abdelmahmuod, Elabbass, et al.
Publicado: (2020) -
Iron Deficiency Anemia-Induced Neutropenia in Adult Female
por: Abdelmahmuod, Elabbass, et al.
Publicado: (2020) -
Patient with clinical celiac disease mimicking triple‐negative essential thrombocythemia
por: Ali, Elrazi A., et al.
Publicado: (2022)